D-1037-2014 Class II Terminated
FDA drug recall D-1037-2014 was initiated by The Mentholatum Co. on Jan 16, 2014 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Rohto Hydra, Rohto Relief and Rohto Cool eye drops, due to concerns related to the quality assurance of… The recall status is terminated (terminated Jun 1, 2018). Affected quantity: 59, 376 units Total (32,184 units held in stock, quarantined).
Recall details
- Product Type
- Drugs
- Report Date
- Feb 5, 2014
- Initiation Date
- Jan 16, 2014
- Termination Date
- Jun 1, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 59, 376 units Total (32,184 units held in stock, quarantined)
Product description
ROHTO Redness Relief, arctic, Redness Reliever, Lubricant Eye Drops, Sterile, Net. Wt. 0.4 FL OZ (13 mL). UPC 3 10742 10909 2, Manufactured by Rohto-Mentholatum (Vietnam) Co., Ltd. for The Mentholatum Company, Orchard Park, NY 14127. Made in Vietnam.
Reason for recall
Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Rohto Hydra, Rohto Relief and Rohto Cool eye drops, due to concerns related to the quality assurance of sterility controls.
Distribution pattern
Nationwide and Puerto Rico
Code information
Stock No: 1090; Case UPC: 3 10742 91080 (2); Item UPC 3 10742 10909 2
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1037-2014
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026